A dermatological composition for inhibiting or treating inflammation and/or aging of skin includes a dermatologically compatible component and cultured cells derived from the Theobroma cacao plant or an extract thereof. The cultured cells including anti-oxidant and/or anti-inflammatory compounds that reduce inflammation and/or aging when delivered to the skin.